M B Rennels

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines
    M B Rennels
    University of Maryland School of Medicine, Baltimore, Maryland, USA
    Pediatrics 105:e12. 2000
  2. ncbi request reprint Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination
    M B Rennels
    University of Maryland School of Medicine, Baltimore, USA
    Pediatr Infect Dis J 19:417-23. 2000
  3. ncbi request reprint Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants
    M B Rennels
    Center for Vaccine Development and Department of Pediatrics, University of Maryland School of Medicine, Baltimore, USA
    Pediatr Infect Dis J 20:153-9. 2001

Detail Information

Publications3

  1. ncbi request reprint Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines
    M B Rennels
    University of Maryland School of Medicine, Baltimore, Maryland, USA
    Pediatrics 105:e12. 2000
    ..However, local reactions increase in rate and severity with each successive DTaP dose, and swelling of the entire injected limb has been reported after booster doses...
  2. ncbi request reprint Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination
    M B Rennels
    University of Maryland School of Medicine, Baltimore, USA
    Pediatr Infect Dis J 19:417-23. 2000
    ..A trial was conducted in which infants received a DTaP and Hib vaccine, separately (+) or combined (/), with either all OPV, all IPV or sequential IPV-OPV for the primary series of vaccinations...
  3. ncbi request reprint Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants
    M B Rennels
    Center for Vaccine Development and Department of Pediatrics, University of Maryland School of Medicine, Baltimore, USA
    Pediatr Infect Dis J 20:153-9. 2001
    ..It appears to be an attractive candidate vaccine for the prevention of serogroup C meningococcal disease in young children...